Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Leslie P. Miranda is active.

Publication


Featured researches published by Leslie P. Miranda.


Archive | 2007

Toxin peptide therapeutic agents

John K. Sullivan; Joseph G. McGivern; Leslie P. Miranda; Hung Q. Nguyen; Kenneth W. Walker; Shaw-Fen Sylvia Hu; Colin V. Gegg


Archive | 2007

GLP-1 compounds

Colin V. Gegg; Leslie P. Miranda; Katherine Ann Winters; Murielle Veniant-Ellison


Archive | 2013

APJ RECEPTOR AGONISTS AND USES THEREOF

Jerry Ryan Holder; Gayathri Swaminath; Leslie P. Miranda; Jennifer Aral; Elizabeth M. Doherty; Thomas Nixey


Archive | 2011

Dipeptides to enhance yield and viability from cell cultures

Sohye Kang; Rohini Deshpande; Rebecca E. Mccoy; Leslie P. Miranda; Arvia E. Morris


Archive | 2006

Cgrp peptide antagonists and conjugates

Colin V. Gegg; Eileen Johnson; Leslie P. Miranda; Kenneth W. Walker; Jerry Ryan Holder; Marie E. Wright; Derin C. D'amico


Archive | 2010

SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3

John K. Sullivan; Leslie P. Miranda; Colin V. Gegg; Shaw-Fen Sylvia Hu; Edward John Belouski; Justin K. Murray; Hung Nguyen; Kenneth W. Walker; Taruna Arora; Frederick W. Jacobsen; Yue-Sheng Li; Thomas C. Boone


Archive | 2007

OSK1 peptide analogs and pharmaceutical compositions

John K. Sullivan; Joseph G. McGivern; Leslie P. Miranda


Archive | 2007

Conjugated toxin peptide therapeutic agents

John K. Sullivan; Joseph G. McGivern; Leslie P. Miranda; Hung Q. Nguyen; Kenneth W. Walker; Shaw-Fen Sylvia Hu; Colin V. Gegg; Taruna Arora Khare; Beverly S. Adler; Francis H. Martin


Archive | 2012

POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7

Justin K. Murray; Leslie P. Miranda


Archive | 2007

Methods of using OSK1 peptide analogs

John K. Sullivan; Joseph G. McGivern; Leslie P. Miranda

Collaboration


Dive into the Leslie P. Miranda's collaboration.

Researchain Logo
Decentralizing Knowledge